About CartiHeal
CartiHeal is a company based in Kfar Saba (Israel) founded in 2009 was acquired by Smith & Nephew in November 2023. CartiHeal has raised $65.8 million across 6 funding rounds from investors including Bioventus, Smith & Nephew and Elron Ventures. CartiHeal operates in a competitive market with competitors including MiMedx Group, Ossio, EpiBone, Biocomposites and Theradaptive, among others.
- Headquarter Kfar Saba, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.8 M (USD)
in 6 rounds
-
Latest Funding Round
$15 M (USD), Series D
Jul 16, 2020
-
Investors
Bioventus
& 7 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CartiHeal
Unlock access to complete
Unlock access to complete
Funding Insights of CartiHeal
CartiHeal has successfully raised a total of $65.8M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $15 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CartiHeal
CartiHeal has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bioventus, Smith & Nephew and Elron Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in healthcare are focused on by aMoon.
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Peregrine is focused on healthcare innovation through strategic global investments.
|
Locked | Locked | Locked |
Investor details for CartiHeal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CartiHeal
Investment portfolio details for CartiHeal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CartiHeal
Detailed financials for CartiHeal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cartiheal Comparisons
Peer comparison for CartiHeal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CartiHeal
CartiHeal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, EpiBone, Biocomposites and Theradaptive, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
|
| Locked | Locked | Locked |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
Detailed competitors of CartiHeal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cartiheal
Complete news archive for CartiHeal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CartiHeal
CartiHeal was founded in 2009 and raised its 1st funding round 3 years after it was founded.
CartiHeal is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
CartiHeal is a funded company, having raised a total of $65.8M across 6 funding rounds to date.
CartiHeal was founded in 2009 in Kfar Saba, Israel, within the medical device sector focused on orthopedics. A cell-free implant named Agili-C has been developed by the company to support bone and cartilage regeneration through a single-step procedure. This implant is CE marked for addressing focal articular cartilage and osteochondral defects in clinical settings. Operations center on advancing regenerative technologies for joint repair.
CartiHeal's top competitors include EpiBone, Theradaptive and MiMedx Group.
CartiHeal has 8 investors. Key investors include Bioventus, Smith & Nephew, Elron Ventures, aMoon, and Johnson & Johnson Innovation – JJDC.